| Therapeutic potential of Chromolaena odorata phyto-constituents against human pancreatic α-amylase B Kikiowo, JA Ogunleye, O Iwaloye, TT Ijatuyi Journal of Biomolecular Structure and Dynamics 40 (4), 1801-1812, 2022 | 40 | 2022 |
| Flavones scaffold of Chromolaena odorata as a potential xanthine oxidase inhibitor: Induced Fit Docking and ADME studies B Kikiowo, AJ Ogunleye, OK Inyang, NS Adelakun, OI Omotuyi, ... BioImpacts: BI 10 (4), 227, 2020 | 26 | 2020 |
| Prospects of essential oils in drug discovery OT Osuntokun, AJ Ogunleye Adv cytol pathol 2 (1), 1-3, 2017 | 21 | 2017 |
| Molecular docking and 3D qsar studies of C000000956 as a potent inhibitor of bace-1 OA Joseph, K Babatomiwa, A Niyi, O Olaposi, I Olumide Drug research 69 (08), 451-457, 2019 | 19 | 2019 |
| Kaempferol as a Potential PAK4 Inhibitor in Triple Negative Breast Cancer: Extra Precision Glide Docking and Free Energy Calculation. MA Arowosegbe, OT Amusan, SA Adeola, OB Adu, IA Akinola, ... Current drug discovery technologies, 2019 | 16 | 2019 |
| Computational construction of a glycoprotein multi-epitope subunit vaccine candidate for old and new South-African SARS-CoV-2 virus strains OO Oluwagbemi, EK Oladipo, EO Dairo, AE Ayeni, BA Irewolede, ... Informatics in Medicine Unlocked 28, 100845, 2022 | 13 | 2022 |
| Induced fit docking and automated QSAR studies reveal the ER-α inhibitory activity of cannabis sativa in breast cancer B Kikiowo, AJ Ogunleye, O Iwaloye, TT Ijatuyi, NS Adelakun, WO Alashe Recent Patents on Anti-Cancer Drug Discovery 16 (2), 273-284, 2021 | 12 | 2021 |
| Virtual screening and pharmacokinetic studies of potential MAO-B inhibitors from traditional Chinese medicine B Kikiowo, JA Ogunleye, DS Metibemu, IO Omotuyi, NS Adelakun Journal of Biological Engineering Research and Review 7 (1), 08-15, 2020 | 12 | 2020 |
| Molecular docking based screening analysis of GSK3B AJ Ogunleye, AJ Olanrewaju, M Arowosegbe, OI Omotuyi Bioinformation 15 (3), 201, 2019 | 11 | 2019 |
| Agemone mexicana flavanones; apposite inverse agonists of the β2-adrenergic receptor in asthma treatment GO Eniafe, DS Metibemu, OI Omotuyi, AJ Ogunleye, OK Inyang, ... Bioinformation 14 (2), 60, 2018 | 9 | 2018 |
| Molecular interaction and inhibitory potential of polyphenol on DNA repair pathway in small cell lung cancer: A computational study OK Inyang, OI Omotuyi, AJ Ogunleye, GO Eniafe, B Adewumi, ... J. Anal. Pharm. Res 6, 00178-00186, 2017 | 8 | 2017 |
| The prospects of medicinal plants in the treatment of breast cancer OA Joseph European Pharmaceutical Review 13, 2016 | 6 | 2016 |
| The importance and efficacy of epigallocatechin and epicatechin TA Aina, OA Joseph, KO Inyang, OO Temitope European Pharmaceutical Review 22 (5), 42-44, 2017 | 5 | 2017 |
| Molecular docking, QSAR and microscopic studies of anti-trypanosomal compounds from the pathogen box AJ Ogunleye, OS Olaolu, NB Ibrahim, AA James Current computer-aided drug design 17 (3), 378-386, 2021 | 3 | 2021 |
| Molecular binding signatures of Trigonella foenum-graecum compounds on cyclin-dependent kinase 4 for possible anti-cancer mechanism in breast cancer EO Aladi, RJ Hadiza, EG Opeyemi, OA Joseph, OE Iyanuoluwa, ... GSC Biological and Pharmaceutical Sciences 11 (3), 014-021, 2020 | 3 | 2020 |
| Salient aspects of PBP2A-inhibition; A QSAR study AJ Ogunleye, GO Eniafe, OK Inyang, B Adewumi, OI Omotuyi Current Computer-Aided Drug Design 14 (4), 363-369, 2018 | 2 | 2018 |
| Computational identification of potential modulators of heme-regulated inhibitor (HRI) for pharmacological intervention against sickle cell disease AJ Owoloye, SO Olubode, A Ogunleye, ET Idowu, KM Oyebola Journal of Biomolecular Structure and Dynamics, 1-13, 2024 | | 2024 |
| Molecular binding signatures of Trigonella foenum-graecum compounds on cyclin-dependent kinase 4 for possible anti-cancer mechanism in breast cancer OA Enejoh, H Rasheed-Jada, GO Eniafe, AJ Ogunleye, EI Oribamise, ... GSC Biological and Pharmaceutical Sciences 11 (3), 041-021, 2020 | | 2020 |
| Evidence for the Immune-Toxicity of Green Tea Polyphenols: A Computational Study AJ Ogunleye, OT Osuntokun, OK Inyang, OI Omotuyi SAJ Pharma Pharmacol 5, 203, 2018 | | 2018 |
| Inhibition of mutant P53 tumour cells by medicinal plants OA Joseph, OO Temitope European Pharmaceutical Review 21 (2), 17-19, 2016 | | 2016 |
